Upgrades and Downgrades - Page 60 | TalkMarkets

Content

All Posts > Content under Upgrades and Downgrades
945 to 960 of 2363 Posts
<<< 1 ... 58 59 60 61 62 ... 148 >>>
Biogen Downgraded To Hold From Buy At Stifel
Article By: The Fly
Thursday, February 21, 2019 8:47 AM EDT
Stifel analyst Paul Matteis downgraded Biogen to Hold from Buy and lowered his price target for the shares to $346 from $397.
In this article: BIIB Also: RHHBY
Read
'Underwhelming' Intercept Data Hurts CymaBay Bear Thesis, Says Piper Jaffray
Article By: The Fly
Wednesday, February 20, 2019 5:48 AM EDT
A major constituent of the CymaBay bear thesis has now been removed.
In this article: CBAY Also: ICPT
Read
Macquarie Upgrades PepsiCo To Outperform, Prefers Over Coca-Cola
Article By: The Fly
Tuesday, February 19, 2019 11:58 AM EDT
Macquarie analyst Caroline Levy is most encouraged by Pepsi's commitment to driving impulse purchases, said she believes the company can deliver 5% average annual sales growth over the next three years.
In this article: PEP, KO
Read
McDonald's Upgraded To Overweight From Equal Weight At Stephens
Article By: The Fly
Tuesday, February 19, 2019 10:00 AM EDT
Stephens analyst Will Slabaugh upgraded McDonald's to Overweight from Equal Weight and raised his price target for the shares to $200 from $180.
In this article: MCD
Read
Macquarie Double Upgrades Exxon To Outperform With $83 Price Target
Article By: The Fly
Thursday, February 14, 2019 9:14 AM EDT
Macquarie analyst David Hewitt double upgraded Exxon Mobil to Outperform from Underperform with a price target of $83.
In this article: XOM
Read
Canaccord Upgrades Tesla To Buy With Model 3, Governance Concerns Eased
Article By: The Fly
Monday, February 11, 2019 9:01 AM EDT
Canaccord upgraded Tesla to Buy from Hold with analyst Jed Dorsheimer stating that he thinks electric vehicle, or EV, penetration is underappreciated by Wall Street.
In this article: TSLA
Read
Bed Bath & Beyond Downgraded To Sell From Hold At Loop Capital
Article By: The Fly
Monday, February 11, 2019 5:29 AM EDT
Loop Capital analyst Anthony Chukumba downgraded Bed Bath & Beyond to Sell and lowered his price target for the shares to $12 from $13.
In this article: BBBY
Read
GrubHub Upgraded To Buy From Neutral At Roth Capital
Article By: The Fly
Friday, February 8, 2019 8:35 AM EDT
Roth Capital analyst Darren Aftahi upgraded GrubHub to Buy from Hold and raised his price target for the shares to $95 from $92.
In this article: GRUB
Read
JPMorgan's Tusa Views GE Stock Rally As Head Scratcher, Keeps $6 Price Target
Article By: The Fly
Friday, February 1, 2019 7:54 AM EDT
JPMorgan analyst Stephen Tusa keeps a Neutral rating on General Electric with a $6 price target.
In this article: GE
Read
Facebook Price Target Raised To $195 From $190 At Piper Jaffray
Article By: The Fly
Thursday, January 31, 2019 7:53 AM EDT
Piper Jaffray analyst Michael Olson raised his price target for Facebook to $195 from $190 and maintains an Overweight rating on the shares following last night's Q4 results.
In this article: META
Read
Baird Downgrades GameStop To Neutral After Company Fails To Find A Buyer
Article By: The Fly
Tuesday, January 29, 2019 10:15 AM EDT
Baird analyst Colin Sebastian downgraded GameStop to Neutral from Outperform and cut his price target on the stock to $12 from $18 after the company announced that its board has ended their efforts to sell the company.
In this article: GME
Read
3D Systems Upgraded To Overweight From Neutral At Piper Jaffray
Article By: The Fly
Tuesday, January 29, 2019 7:40 AM EDT
Piper Jaffray analyst Troy Jensen upgraded 3D Systems to Overweight from Neutral with an unchanged price target of $17.
In this article: SSYS
Read
Sonos Upgraded To Overweight From Equal Weight At Morgan Stanley
Article By: The Fly
Monday, January 28, 2019 10:46 AM EDT
Morgan Stanley analyst Yuuji Anderson upgraded Sonos to Overweight from Equal Weight, stating that he has become more confident that new products will drive growth and margin expansion.
In this article: SONO
Read
Goldman Downgrades Crispr Therapeutics To Neutral On Lack Of 2019 Catalysts
Article By: The Fly
Monday, January 28, 2019 7:59 AM EDT
Goldman Sachs analyst Salveen Richter downgraded Crispr Therapeutics to Neutral and cut his price target for the shares to $40 from $78.
In this article: CRSP Also: BLUE
Read
PG&E Price Target Raised To $17.50 Following Cal Fire Report At Morgan Stanley
Article By: The Fly
Friday, January 25, 2019 10:48 AM EDT
Morgan Stanley analyst Stephen Byrd raised his price target on PG&E shares to $17.50 from $13.00 after Cal Fire released its investigative report on the Tubbs Fire.
In this article: PCG
Read
Canopy Growth Price Target Raised To $60 From $40 At Piper Jaffray
Article By: The Fly
Friday, January 25, 2019 7:45 AM EDT
Piper Jaffray analyst Michael Lavery raised his price target for Canopy Growth Corporation to $60 from $40 and keeps an Overweight rating on the shares.
In this article: CGC
Read
945 to 960 of 2363 Posts
<<< 1 ... 58 59 60 61 62 ... 148 >>>